These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20550020)

  • 1. Acute dopamine-agonist treatment in restless legs syndrome: effects on sleep architecture and NREM sleep instability.
    Ferri R; Manconi M; Aricò D; Sagrada C; Zucconi M; Bruni O; Oldani A; Ferini-Strambi L
    Sleep; 2010 Jun; 33(6):793-800. PubMed ID: 20550020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the boundaries of the response of sleep leg movements to a single dose of dopamine agonist.
    Manconi M; Ferri R; Feroah TR; Zucconi M; Ferini-Strambi L
    Sleep; 2008 Sep; 31(9):1229-37. PubMed ID: 18788648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
    Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M
    Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
    Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
    Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of periodic leg movements from arousals in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L
    Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep.
    Manconi M; Ferri R; Zucconi M; Clemens S; Rundo F; Oldani A; Ferini-Strambi L
    Sleep Med; 2011 Jan; 12(1):47-55. PubMed ID: 20851046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonists for restless legs syndrome.
    Scholz H; Trenkwalder C; Kohnen R; Riemann D; Kriston L; Hornyak M
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD006009. PubMed ID: 21412893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
    Montplaisir J; Nicolas A; Denesle R; Gomez-Mancilla B
    Neurology; 1999 Mar; 52(5):938-43. PubMed ID: 10102409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
    Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
    Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
    Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
    Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.